Abstract

BackgroundSputum and blood eosinophil counts predict corticosteroid effects in COPD patients. Bacterial infection causes increased airway neutrophilic inflammation. The relationship of eosinophil counts with airway bacterial load in COPD patients is uncertain. We tested the hypothesis that bacterial load and eosinophil counts are inversely related.MethodsCOPD patients were seen at stable state and exacerbation onset. Sputum was processed for quantitative polymerase chain reaction detection of the potentially pathogenic microorganisms (PPM) H. influenzae, M. catarrhalis and S. pneumoniae. PPM positive was defined as total load ≥1 × 104copies/ml. Sputum and whole blood were analysed for differential cell counts.ResultsAt baseline, bacterial counts were not related to blood eosinophils, but sputum eosinophil % was significantly lower in patients with PPM positive compared to PPM negative samples (medians: 0.5% vs. 1.25% respectively, p = 0.01). Patients with PPM positive samples during an exacerbation had significantly lower blood eosinophil counts at exacerbation compared to baseline (medians: 0.17 × 109/L vs. 0.23 × 109/L respectively, p = 0.008), while no blood eosinophil change was observed with PPM negative samples.ConclusionsThese findings indicate an inverse relationship between bacterial infection and eosinophil counts. Bacterial infection may influence corticosteroid responsiveness by altering the profile of neutrophilic and eosinophilic inflammation.

Highlights

  • Sputum and blood eosinophil counts predict corticosteroid effects in Chronic obstructive pulmonary disease (COPD) patients

  • Retrospective analysis of COPD clinical trials have shown that higher blood eosinophil counts predict a greater reduction in exacerbation rates with inhaled corticosteroid/long acting beta agonist (ICS/Long acting beta agonist (LABA)) combinations compared to LABA [8,9,10]

  • We investigated the relationship between eosinophil counts and the bacterial load in the stable state and during exacerbations in COPD patients

Read more

Summary

Introduction

Sputum and blood eosinophil counts predict corticosteroid effects in COPD patients. COPD is a heterogeneous condition, composed of different clinical and pathophysiological components that vary both in presence and severity between patients [1]. This heterogeneity causes variability in the responses to pharmacological treatments. Sputum eosinophil counts in stable COPD patients predict the clinical response to corticosteroids [2, 3]. Oral corticosteroid treatment during exacerbations has a greater effect in COPD patients with higher blood eosinophil counts [11]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call